Transfemoral access for valve in valve implantation of an Edwards Sapien XT valve in a stenotic tricuspid bioprosthesis under fluoroscopic guidance.

Abstract	A 53-year-old man presented with a high grade stenotic tricuspid bioprosthesis and an inoperable state because of progressive lung disease. Valve replacement was performed transfemorally under local anaesthesia without rapid pacing. Valve positioning was facilitated by the radiopaque frame of the degenerated bioprosthesis. Echocardiography revealed a decrease of peak tricuspid valve gradient from 18 to 8 mm Hg. Valve-in-valve implantation of an Edwards Sapien XT valve in a failing tricuspid bioprosthesis is feasible via transfemoral access without general anaesthesia or rapid pacing.
Authors	Martin Greif, Rene Schramm, Gerhard Steinbeck, Christian Hagl, Christoph Schmitz, Christian Kupatt
Journal	The Canadian journal of cardiology (Can J Cardiol) Vol. 29 Issue 8 Pg. 1014.e3-4 (Aug 2013) ISSN: 1916-7075 [Electronic] England
PMID	23406738 (Publication Type: Case Reports, Journal Article)
Copyright	Copyright © 2013 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
Topics	Bioprosthesis (adverse effects) Cardiac Catheterization (methods) Echocardiography Femoral Artery (surgery) Fluoroscopy Heart Valve Prosthesis (adverse effects) Heart Valve Prosthesis Implantation (adverse effects, methods) Humans Male Middle Aged Treatment Outcome Tricuspid Valve (surgery) Tricuspid Valve Stenosis (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!